Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21:1067–96.

Article  CAS  PubMed  Google Scholar 

Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62.

Article  CAS  PubMed  Google Scholar 

Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV. Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US. JAMA Netw Open. 2023;6:e231439.

Article  PubMed  PubMed Central  Google Scholar 

Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990–2013. JAMA. 2015;314:80.

Article  CAS  PubMed  Google Scholar 

Liu Y, Hall IJ, Filson C, Howard DH. Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer. Urol Oncol. 2021;39:432.e1–432.e10.

Article  PubMed  Google Scholar 

Gravas S, Malde S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, et al. From BPH to male LUTS: a 20-year journey of the EAU guidelines. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00700-3.

Bajpai RR, Razdan S, Sanchez-Gonzalez MA, Reddy BN, Razdan S. Robot-assisted radical prostatectomy after prior transurethral resection of prostate: an analysis of perioperative, functional, pathologic, and oncologic outcomes. J Endourol. 2022;36:1063–9.

Article  PubMed  Google Scholar 

Kretschmer A, Mazzone E, Barletta F, Leni R, Heidegger I, Tsaur I, et al. Initial experience with radical prostatectomy following holmium laser enucleation of the prostate. Eur Urol Focus. 2021;7:1247–53.

Article  PubMed  Google Scholar 

Liadi Y, Campbell T, Dike P, Harlemon M, Elliott B, Odero-Marah V. Prostate cancer metastasis and health disparities: a systematic review. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00667-1.

Scheipner L, Incesu RB, Morra S, Baudo A, Assad A, Jannello LMI, et al. Characteristics of incidental prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00742-7.

Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, et al. Incidental prostate cancer (cT1a–cT1b) Is a relevant clinical and research entity and should be fully discussed in the international prostate cancer guidelines. Eur Urol Oncol. 2022;5:256–8.

Article  Google Scholar 

Han EA, Nandalur KR, Morgan MA, Arora SS, Loening AM, Bivalacqua TJ, et al. MRI of benign prostatic hyperplasia: important pre- and posttherapeutic considerations. RadioGraphics. 2023;43 https://doi.org/10.1148/rg.220096.